Overview of clinical data for Orlistat pdf

Clinical trials of Orlistat (orlistat) and the meta-analysis of their results are available for the following clinical conditions:

diabetes

all type of patients (in overview of all prevention) pdf

orlistat vs placebo : Heymsfield ,2000 - XENDOS (Chiasson) ,2002 -

people with impaired glucose tolerance (in overview of all prevention) pdf

orlistat vs placebo : Heymsfield ,2000 - XENDOS (Chiasson) ,2002 -

obesity and overweight

all type of patients (in overview of all All mecanism) pdf

Orlistat vs placebo : Bakris ,2002 - Broom ,2002 - Broom, ,2001 - Davidson ,1999 - Deerochanawong, ,2001 - Derosa ,2003 - Gotfredsen ,2001 - Halpern ,2003 - Hanefeld ,2002 - Hauptman ,2000 - Hill ,1999 - Hollander ,1998 - Karhunen ,2000 - Kelley ,2002 - Krempf ,2005 - Lindgarde ,2000 - Lucas ,2003 - Micic ,1999 - Miles ,2002 - Muls ,2001 - Naumov ,2002 - Reaven ,2001 - Rissanen ,2001 - Rosenfalck ,2002 - Rossner ,2000 - Shi Yi ,2001 - Sjostrom ,1998 - Vidgren ,1999 -

Entry terms: tetrahydrolipstatin, orlistat, tetrahydrolipstatin, THLP, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate, Alli, GlaxoSmithKline brand of orlistat, Xenical, Roche brand of orlistat, Hoffmann-La Roche brand of orlistat, N-formyl-1-((3-hexyl-4-methylene-2-oxetanyl)methyl)dodecyl 2-amino-4-methylpentanoate, 2-deoxo-2-methylene orlistat

See also relatic topics: